Who is Meg G. Crofton and why was she appointed to the HCA Healthcare Board?

Meg G. Crofton has been appointed to the HCA Healthcare Board of Directors. While the filing doesn't detail her specific qualifications beyond her appointment to key committees, such appointments typically aim to bring diverse expertise to the board, particularly in areas like compensation, governance, and patient care, which are crucial for a company like HCA.

What is the significance of the Board size increasing?

The increase in Board size from 12 to 13 directors allows for the addition of new expertise and perspectives. This is a common practice to ensure the Board has a comprehensive range of skills to oversee the company's strategy and operations effectively.

What is the impact of Ann H. Lamont's retirement on the company?

Ann H. Lamont's retirement at the upcoming annual meeting signifies a transition on the Board. Her departure, coupled with the addition of Ms. Crofton, suggests a strategy of board refreshment, bringing in new talent while acknowledging the contributions of departing members.

Are there any conflicts of interest related to Ms. Crofton's appointment?

The filing explicitly states there are no arrangements or understandings with other parties regarding Ms. Crofton's selection, nor is she related to any current executive officers or directors. Furthermore, there are no reportable transactions requiring disclosure under SEC regulations, indicating no immediate conflicts of interest are apparent from this filing.

HCA 8-K: Leadership Changes

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on February 25, 2019, primarily to announce changes to its Board of Directors. Meg G. Crofton was appointed to the Board, effective March 1, 2019, increasing the Board's size to 13 members. Ms. Crofton will serve on the Compensation Committee and the Patient Safety and Quality of Care Committee. This appointment adds significant experience to the board, particularly in areas critical to a healthcare company's operations and governance. In addition, Ann H. Lamont informed the company of her intention to retire from the Board at the conclusion of her term during the 2019 annual stockholder meeting. These changes reflect ongoing board refreshment and governance practices designed to enhance strategic oversight and operational effectiveness for HCA Healthcare.

Key Highlights

1Meg G. Crofton appointed to the Board of Directors, effective March 1, 2019.
2Board size increases from 12 to 13 directors.
3Ms. Crofton will serve on the Compensation Committee and the Patient Safety and Quality of Care Committee.
4Ann H. Lamont will retire from the Board at the 2019 annual stockholder meeting.
5The appointment is made in accordance with the company's Amended and Restated Certificate of Incorporation.
6No undisclosed arrangements or family ties between Ms. Crofton and existing officers/directors.
7No reportable transactions for Ms. Crofton under Item 404(a) of Regulation S-K.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Feb 25, 2019)

Summary

Key Highlights

Frequently Asked Questions